Please login to the form below

Not currently logged in
Email:
Password:

Hill+Knowlton appoints new healthcare director

Mary Hicks joins the agency from TogoRun
HK,-Mary-Hicks

London-based communications agency Hill+Knowlton (H+K) has appointed Mary Hicks as a director in its healthcare division.

In this role she will run UK programmes for a number of pharmaceutical companies while also leading the agency's Harley St. Clinic account.

Over her 20-year career, Hicks' healthcare public relations experience has covered creative media campaigns, stakeholder engagement programmes, and working with advocacy groups.

She has developed several Communiqué Award-winning campaigns, led Bristol-Myers Squibb's immuno-oncology portfolio, and also co-founded the PR agency Clew Communications.

“Mary is a great asset to our team and clients with her deep understanding of the communications needs of the pharmaceutical industry and ability to communicate with stakeholders at all levels,” said Sue Cook, managing director, Healthcare and Medical Knowledge Group, H+K.

Hick's appointment is one of several recent additions to H+K's Healthcare team that include those of David Bowen as global head of healthcare and Sue Cook as managing director at the London office.

1st August 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics